These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Listed as ongoing, but also has a completion date and reported results 2004-005285-20 Treatment of Acute Migraine when Pain is Mild versus when Pain is Moderate to Severe an Almotriptan Parallel, Placebo Controlled Clinical Trial. Act when mild 2006-05-09 bad-data
Completed, but no date, and reported results 2005-000244-90 A randomized, prospective, cross-over, double blind, placebo-controlled multicentre study to assess the efficacy and tolerability of almotriptan 12.5 mg in the mild pain phase of Mestrual Migraine fol... bad-data
Completed, but no date, and reported results 2005-003162-42 A double-blind, randomized, parallel, multicenter, vehicle-controlled, left/right paired comparison to study the efficacy, safety and tolerability of 1% LAS 37779 cream administered once and twice dai... bad-data
Listed as ongoing, but also has a completion date and reported results 2005-005101-39 A 52-WEEK RANDOMISED, DOUBLE-BLIND, PARALLEL GROUP, PLACEBO CONTROLLED, MULTICENTRE CLINICAL TRIAL, TO ASSESS THE EFFICACY AND SAFETY OF 200 g OF THE ANTICHOLINERGIC LAS 34273 COMPARED TO PLACEBO, ... 2008-07-31 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-005804-17 A Single Dose, Double-Blind, Double-Dummy, 3 Period Cross-Over, Placebo Controlled Clinical Trial To Assess the Rate of Onset of Action of Inhaled LAS 34273 200µg Compared To Placebo and Tiotropium 18... 2007-08-10 bad-data
Ongoing, reported early 2006-000334-12 A RANDOMIZED, PLACEBO CONTROLLED, DOUBLE-BLIND, CROSS-OVER, MONOCENTER STUDY TO EVALUATE THE EFFECT OF A 7-DAY MONTELUKAST TREATMENT ON AIRWAY INFLAMMATION AND FUNCTION BY MEANS OF BRONCHOPROVOCATION ... not-yet-due
Reported results 2006-002410-35 Double-blind, double-dummy, randomized, placebo-controlled, five-armed, multi-centre phase II/III study to evaluate the efficacy and safety of different concentrations of isotretinoin versus doxycycli... 2008-07-31 due-trials
Ongoing, reported early 2006-004874-29 EVAluation par une echelle visuelle analogique de la satisfaction de patients migraineux apres traitement de 3 crises consécutives par Almogran not-yet-due
Reported results 2007-000010-36 A multiple dose, double-blind, double-dummy, 3 period cross-over, placebo controlled clinical trial to assess the efficacy and safety of once daily inhaled aclidinium bromide 200 µg given either in th... 2008-03-13 due-trials
Reported results 2007-000093-23 Clinical trial to investigate clinical efficacy and tolerability of Tretinoin in actinic keratosis 2008-12-02 due-trials
Reported results 2007-001793-87 A Multicenter, Randomized, Double-Blind, Parallel-Group, Vehicle and Active Controlled Trial, to Assess the Efficacy and Safety of LAS37779 Cream for the Treatment of Chronic Plaque Psoriasis 2008-01-21 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-003392-39 Standardized sTudy with Almotriptan in eaRly Treatment of migraine, START. An international, open label, single arm, effectiveness and safety study of Almotriptan in primary care 2009-03-23 bad-data
Reported results 2007-003415-31 A PHASE IIa, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO AND ACTIVE COMPARATOR CONTROLLED, 5-WAY CROSSOVER CLINICAL TRIAL TO ASSESS THE ACTIVITY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF SING... 2008-02-19 due-trials
Reported results 2007-003648-31 A phase IIa, randomised, multicentre, evaluator-blinded, 4-way crossover clinical trial to study the pharmacokinetics, safety, tolerability and effects on lung function of one day treatment of formote... 2007-12-12 due-trials
Reported results 2007-003889-18 Study on the efficacy of Verrumal(R) compared to placebo and Solaraze(R) in the treatment of actinic keratosis grade I to II 2009-10-07 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-004435-30 A randomised, 4-week, placebo-controlled, double-blind, 6 arm parallel group, dose-finding clinical trial, to assess the efficacy and safety of three different doses of formoterol (6, 12 & 18µg) combi... 2008-11-10 bad-data
Reported results 2008-002141-24 A phase II, single-center, randomized, controlled, observer-blind study to determine the non-inferiority of a topical mometasone formulation vs a marketed comparator by evaluation of the anti-psoriati... 2008-07-25 due-trials
Reported results 2008-003362-26 A phase IIa single-center, randomized, controlled, observer-blind study to investigate the antimicrobial efficacy of topical formulations containing octenidine and prednicarbate in an"expanded flora t... 2008-10-10 due-trials
Reported results 2008-003732-38 A PHASE IIa, RANDOMISED, DOUBLE-BLIND, MULTIPLE DOSE, PLACEBO CONTROLLED, 3 PERIOD CROSS-OVER, ASCENDING DOSE CLINICAL TRIAL TO ASSESS THE EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF THREE ... 2008-12-08 due-trials
Reported results 2008-004756-69 A randomised, double-blind, placebo-controlled, 4-way crossover clinical trial to assess the efficacy, safety, tolerability and pharmacokinetics of single doses of LAS100977 administered by inhalation... 2009-02-18 due-trials
Reported results 2008-006886-10 A multiple dose, double blind, double-dummy, two-week 3 way cross-over, placebo-controlled clinical trial to assess the efficacy and safety of twice daily inhaled Aclidinium-bromide 400 µg compared to... 2009-07-01 due-trials
Reported results 2009-009948-23 A phase IIa single-center, randomized, controlled, observer-blind study to investigate the antimicrobial efficacy of topical formulations containing octenidine and prednicarbate in an "expanded flora ... 2009-06-10 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-011600-27 Efficacia e sicurezza di aclidinio bromuro a due livelli di dose rispetto a placebo per il trattamento di pazienti con broncopneumopatia cronica ostruttiva (BPCO) da moderata a grave 2010-11-08 bad-data
Reported results 2009-011931-11 Explorative, double-blind, randomized, controlled multi-center phase II study to evaluate the efficacy and safety of topically applied combinational product LAS41003 once daily versus corresponding mo... 2010-06-29 due-trials
Reported results 2009-012063-33 Double-blind, randomized, multi-centre phase II study to evaluate the efficacy and safety of topically applied LAS41007 once daily and LAS41007 twice daily versus Solaraze® 3% gel twice daily in the t... 2010-01-25 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-015901-38 Efficacy, safety and tolerability of two Fixed-Dose Combinations of Aclidinium bromide with two doses of Formoterol fumarate compared with Aclidinium bromide, Formoterol fumarate and placebo all admin... 2010-10-22 bad-data
Reported results 2009-016261-28 Randomized, observer-blind, multi-center, reference-controlled phase IIb study to evaluate the efficacy of topically applied LAS41002 lotion in the treatment of scalp psoriasis 2010-04-19 due-trials
Reported results 2009-016626-14 A Phase IIa, two-center, randomized, double-blind study with parallel groups to evaluate the anti-mycotic and anti-inflammatory efficacy of topical combinational product LAS 41003 versus corresponding... 2010-06-16 due-trials
Reported results 2009-016627-56 A phase IIa, multi-center, randomized, double-blind study to evaluate the anti-mycotic and anti-inflammatory efficacy of topical combinational product LAS 41003 versus corresponding mono-substances in... 2011-07-08 due-trials
Reported results 2009-016629-33 A 12 day placebo- and reference-controlled, double-blind, single center, randomized, phase II clinical study with an intraindividual comparison, investigating the anti-psoriatic efficacy and the toler... 2010-03-05 due-trials
Reported results 2009-017380-42 Efficacy and safety of three doses of aclidinium bromide compared to placebo and to an active comparator all administered twice daily by inhalation in patients with stable moderate and severe chronic ... 2010-08-20 due-trials
Reported results 2009-017407-28 A phase II, single-center, randomized, controlled, double-blind study to assess effects on skin conditions and patient reported outcome of a topical formulation containing LAS41002 on lesional skin in... 2010-03-29 due-trials
Reported results 2010-018355-10 An Investigator-blind, Controlled Study to Assess the Efficacy of Five Distinct Combinations of LAS 41004 in Different Concentrations Compared to Placebo and to Two Active Controls in a Psoriasis-Plaq... 2010-09-06 due-trials
Reported results 2010-022244-20 Double-blind, randomized, vehicle- and comparator-controlled, multicenter trial to evaluate the efficacy and safety of LAS41007 in the treatment of actinic keratosis 2012-07-16 due-trials
Reported results 2010-022281-27 An Investigator-blind, Controlled Study to Assess the Efficacy and Safety of different formulations of LAS 41004 Compared to Placebo and to Active Control in a Psoriasis-Plaque-Test 2011-02-28 due-trials
Reported results 2010-022980-37 A prospective comparator controlled randomized exploratory study on the efficacy of LAS 41005 compared to cryotherapy in subjects with hyperkeratotic actinic keratosis 2012-08-20 due-trials
Reported results 2011-000186-13 An Investigator-blind, Controlled Exploratory Study to Assess the Efficacy and Safety of Different Concentrations of Active Ingredients in the project Formulations of LAS 41004 Compared to a Bland Oin... 2011-07-11 due-trials
Reported results 2011-000428-14 A PHASE IIA, RANDOMISED, SINGLE DOSE, DOUBLE-BLIND, DOUBLE-DUMMY, 6 WAY COMPLETE CROSS-OVER, PLACEBO CONTROLLED CLINICAL TRIAL TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF 4 DOSES OF LAS100977 Q... 2012-01-23 due-trials
Reported results 2011-000429-58 A PHASE IIA, RANDOMISED, SINGLE DOSE, DOUBLE-BLIND, DOUBLE-DUMMY, 6 WAY COMPLETE CROSS-OVER, PLACEBO CONTROLLED CLINICAL TRIAL TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF 4 STRENGTHS OF LAS1009... 2011-12-27 due-trials
Reported results 2011-000834-12 A MULTIPLE DOSE, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO CONTROLLED, PARALLEL CLINICAL TRIAL TO ASSESS THE EFFICACY AND SAFETY OF TWICE DAILY INHALED ACLIDINIUM BROMIDE 400 μg COMPARED TO PLACEBO AND TO T... 2012-03-15 due-trials
Reported results 2011-001384-45 A 22 day bland ointment and reference-controlled, investigator-blind, single center, randomized, proof of concept clinical study with an intraindividual comparison investigating the anti-psoriatic eff... 2011-08-12 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-001524-38 EFFICACY AND SAFETY OF ACLIDINIUM BROMIDE/FORMOTEROL FUMARATE FIXED-DOSE COMBINATIONS COMPARED WITH INDIVIDUAL COMPONENTS AND PLACEBO WHEN ADMINISTERED TO PATIENTS WITH STABLE CHRONIC OBSTRUCTIVE PULM... 2013-01-04 bad-data
Completed, but no date, and reported results 2011-002258-30 NEUROPHYSIOLOGIC STUDY AIMED AT EVALUATING ON EFFECT OF SATIVEX® ON SPASTICITY IN PROGRESSIVE MULTIPLE SCLEROSIS bad-data
Reported results 2011-002665-38 A MULTIPLE DOSE, RANDOMISED, DOUBLE-BLIND, PLACEBO CONTROLLED, 2 PERIOD CROSSOVER CLINICAL TRIAL TO ASSESS THE EFFECT OF ACLIDINIUM BROMIDE 400 MCG BID ON EXERCISE ENDURANCE IN PATIENTS WITH STABLE MO... 2012-06-04 due-trials
Reported results 2012-000055-13 A multi-center, randomized, double-blind, three-arm, 16 week, adaptive phase III clinical study to investigate the efficacy and safety of LAS41008 vs LASW1835 and vs Placebo in patients with moderate... 2015-10-03 due-trials
Reported results 2013-000116-14 A RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, ACTIVE-CONTROLLED STUDY EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF TWICE-DAILY ACLIDINIUM BROMIDE /FORMOTEROL FUMARATE COMPARED WITH TWICE-DAILY SALM... 2014-08-04 due-trials
Ongoing 2013-001248-67 CLINICAL TRIAL PHASE IIIb to evaluate predictors of response to linaclotide in patients with irritable bowel syndrome and explore the impact on intestinal symptoms not-yet-due
Reported results 2013-003373-10 A DOUBLE-BLIND, PLACEBO-CONTROLLED, 2 PERIOD CROSSOVER CLINICAL STUDY TO ASSESS THE EFFECT OF ACLIDINIUM BROMIDE 400 ΜCG BID ON COPD SYMPTOMS AND SLEEP QUALITY AFTER 3 WEEKS OF TREATMENT IN PATIENTS W... 2015-06-03 due-trials
Reported results 2013-003757-22 A phase IIa, 28-day treatment, multi-center, randomized, comparator-controlled, observer-blind trial with intra-individual left/right comparison to investigate the anti-psoriatic efficacy and the safe... 2014-10-13 due-trials
Reported results 2013-004519-28 A phase II trial to evaluate the anti-psoriatic efficacy and tolerability of tazarotene in a gel formulation in patients with mild to moderate nail psoriasis - parallel group comparison 2015-05-07 due-trials
Reported results 2014-001171-31 Multicentre, randomized, parallel, double-blind, vehicle controlled study to evaluate the efficacy and safety of Actikerall® solution in the field-directed treatment of actinic keratoses grade I to II... 2015-08-10 due-trials
Reported results 2015-004451-40 SATIVEX® AS ADD-ON THERAPY VS. FURTHER OPTIMIZED FIRST-LINE ANTISPASTICS 2017-05-23 due-trials
Ongoing 2017-001368-40 Open clinical study to assess long-term efficacy and safety of dimethyl fumarate in adults with moderate to severe chronic plaque psoriasis in real practice (DIMESKIN 1 Trial) not-yet-due